Inhibitors of alpha-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson's disease and related disorders.

D.A.M. Amer, Brent Irvine, O.M.A. El-Agnaf

Research output: Contribution to journalArticlepeer-review

58 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Inhibitors of alpha-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson's disease and related disorders.'. Together they form a unique fingerprint.

Medicine & Life Sciences